Trials / Sponsors / David Bushnell
David Bushnell
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 | EARLY_Phase 1 | 2023-11-10 |
| Withdrawn | A Clinical Trial Evaluating the Safety of Combining Lutathera(R) and Azedra(R) to Treat Mid-gut Neuroendocrine Gastro-enteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors | Phase 1 / Phase 2 | 2022-09-30 |
| Active Not Recruiting | Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors Neuroendocrine Tumor, Malignant, Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting | EARLY_Phase 1 | 2017-05-07 |
| Completed | Combination Targeted Radiotherapy in Neuroendocrine Tumors Neuroendocrine Tumors | N/A | 2006-09-01 |